Scalper1 News
Earnings season is still chugging along past Presidents Day, with several major drugmakers and technology companies yet to disclose eagerly anticipated results. Today’s IBD 50 roundup takes a peek at two hot biotechs and one laser-focused tech firm reporting this week. Actavis (ACT) has already offered an early view of results. The Dublin-headquartered specialty pharmaceutical company hyped up Q4 figures last month when it said that its earnings Scalper1 News
Scalper1 News